Italians to enjoy medical marijuana offers from one of the largest cannabis companies in the world

Tilray Brands, Inc. TLRY (NASDAQ:TLRY) (TSX:TLRY) announced that its medical cannabis division, Tilray Medical and FL Group, the company’s subsidiary in Italy, has received permission from Italy’s Ministry of Health to distribute three new medical cannabis compounds. These medicinal cannabis compounds will be distributed by FL Group to pharmacies throughout Italy, further expanding its portfolio of pharmaceutical grade cannabis offerings. Tilray also announced a new strategic partnership with Pharmaidea, -one Petrone Group company, to market and educate over 12,000 pharmacies across Italy about the benefits of medical cannabis and medical cannabis patient care.

Tilray Medical has an established broad national pharmaceutical distribution network in Italy, where medical cannabis is reimbursed by the health system for eligible patients. Tilray’s new medical cannabis authorizations include three cannabis extracts that are made available to patients through pharmaceutical compounding by pharmacists. Doctors can now prescribe Tilray-supplied medicinal cannabis extracts in various concentrations across the country.

Denise FaltischekChief Strategy Officer and Head of International, Tilray Brands, said: “We are delighted to expand our medical cannabis offering to Italy and support pharmacies with medical cannabis education through our new Pharmaidea partnership. We are extremely humbled by the trust that patients, healthcare providers and governments have shown us and our medical cannabis products and take our responsibility very seriously.Our Tilray Medical team remains dedicated to patient advocacy and education across our international markets while providing quality, consistent medical cannabis for commercial, compassionate access and research purposes .”

Tilray Medical supports NECESSITY, a cancer and patient care conference. The conference is accredited by the Italian Ministry of Health and led by Dr. Vittorio A. Guardamagnanational coordinator and director of pain management and palliative care at the European Institute of Oncology, Milan.

Conference participants will share experiences in daily practice, discuss integrated and multidisciplinary therapeutic strategies and elaborate on the guidelines for the results of clinical trials and the introduction of therapeutic preparations based on medical cannabis. The ONCOWELLNESS conference will be held in Milan on 27 May 2023, in Florence at Careggi Hospital on 9 September 2023 and in Bari at UNIBA University Hospital on 18 November 2023.

Photo by Tim Foster on Unsplash.

HEXO Corp. advances agreement with Tilray Brands Inc.

Italians to enjoy medical marijuana offers from one of the largest cannabis companies in the world

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top